EGLN1 and hereditary clear cell renal cell carcinoma: Recently, a similar finding demonstrated that Se-methylselenocysteine inhibited HIF-1α in renal cell carcinoma through a PHD2-dependent and Von-Hippel-Lindau-independent degradation mechanism 37.